FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

14254811000001107: Aliskiren hemifumarate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    50532101000001113 Aliskiren hemifumarate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    50532201000001118 Aliskiren hemifumarate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Aliskiren hemifumarate Is a Aliskiren false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Rasilez 150mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (CST Pharma Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (CST Pharma Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (CST Pharma Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Aliskiren 150mg tablets Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Aliskiren 300mg tablets Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Waymade Healthcare Plc) Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Waymade Healthcare Plc) 28 tablet Has active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren fumarate 300 milligram/1 each conventional release oral tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Aliskiren 300mg tablets 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Product containing precisely aliskiren fumarate 150 milligram/1 each conventional release oral tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Waymade Healthcare Plc) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Aliskiren 150mg tablets 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Waymade Healthcare Plc) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Waymade Healthcare Plc) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Lexon (UK) Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Aliskiren 300mg tablets 30 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Aliskiren 150mg tablets 30 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Waymade Healthcare Plc) 30 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Waymade Healthcare Plc) 30 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 150mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier
    Rasilez 300mg tablets (Doncaster Pharmaceuticals Ltd) 28 tablet Has specific active ingredient False Aliskiren hemifumarate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start